Literature DB >> 1688421

Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein.

M T Dertzbaugh1, D L Peterson, F L Macrina.   

Abstract

A synthetic peptide, encoding amino acid residues 345 to 359 of the glucosyltransferase B enzyme of Streptococcus mutans GS-5, was genetically fused to the N-terminal end of the B-subunit gene of cholera toxin. The protein was overexpressed in Escherichia coli and retained the antigenicity associated with cholera toxin B subunit (CTB) as well as that associated with glucosyltransferase B. The addition of 15 amino acids to the N-terminal end of CTB did not appear to affect the gross structure of the protein significantly. The chimeric protein monomers assembled into a functional oligomer which exhibited only minor conformational differences from native CTB as measured by circular dichroism. The chimera bound to GM1 ganglioside and thus retained the biological activity of CTB. These results demonstrate that genetic fusion of small peptides to the N terminus of CTB has only a minimal effect on the structure and function of the protein. Furthermore, the chimera was shown to be immunogenic when fed to mice. This work has important implications in the construction of CTB chimeras for use as oral vaccines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688421      PMCID: PMC258410          DOI: 10.1128/iai.58.1.70-79.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.

Authors:  C Czerkinsky; M W Russell; N Lycke; M Lindblad; J Holmgren
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

3.  Chemistry of antibody binding to a protein.

Authors:  H M Geysen; J A Tainer; S J Rodda; T J Mason; H Alexander; E D Getzoff; R A Lerner
Journal:  Science       Date:  1987-03-06       Impact factor: 47.728

4.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

5.  Correlation between segmental mobility and the location of antigenic determinants in proteins.

Authors:  E Westhof; D Altschuh; D Moras; A C Bloomer; A Mondragon; A Klug; M H Van Regenmortel
Journal:  Nature       Date:  1984 Sep 13-19       Impact factor: 49.962

6.  Tapping the immunological repertoire to produce antibodies of predetermined specificity.

Authors:  R A Lerner
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

7.  Cloning of a Streptococcus mutans glucosyltransferase gene coding for insoluble glucan synthesis.

Authors:  H Aoki; T Shiroza; M Hayakawa; S Sato; H K Kuramitsu
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

8.  Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.

Authors:  J B Kaper; H Lockman; M M Baldini; M M Levine
Journal:  Nature       Date:  1984 Apr 12-18       Impact factor: 49.962

9.  Antibodies against synthetic peptides as a tool for functional analysis of the transforming protein pp60src.

Authors:  T Tamura; H Bauer; C Birr; R Pipkorn
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

10.  Secretion cloning vectors in Escherichia coli.

Authors:  J Ghrayeb; H Kimura; M Takahara; H Hsiung; Y Masui; M Inouye
Journal:  EMBO J       Date:  1984-10       Impact factor: 11.598

View more
  23 in total

1.  A method for soluble overexpression of the alpha7 nicotinic acetylcholine receptor extracellular domain.

Authors:  M Fischer; P J Corringer; K Schott; A Bacher; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Antibody to glucosyltransferase induced by synthetic peptides associated with catalytic regions of alpha-amylases.

Authors:  D J Smith; R L Heschel; W F King; M A Taubman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  An HIV-1 tat-autoantigen fusion protein suppresses insulitis in NOD mice.

Authors:  Tae-Geum Kim; Jie Yu; John Hough; David Henderson; William H R Langridge
Journal:  Mol Biotechnol       Date:  2005-07       Impact factor: 2.695

4.  Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.

Authors:  Tetsuya Harakuni; Hideki Sugawa; Ai Komesu; Masayuki Tadano; Takeshi Arakawa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 5.  Progress towards development of a vaccine for amebiasis.

Authors:  S L Stanley
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

6.  Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.

Authors:  M T Dertzbaugh; C O Elson
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.

Authors:  M W Russell; Z Moldoveanu; P L White; G J Sibert; J Mestecky; M Michalek S
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 9.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

10.  Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.

Authors:  T Zhang; E Li; S L Stanley
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.